Search Press releases Keywords From To 30 Sep 2026 UCB announces new data at EADV 2026 supporting earlier use of BIMZELX[®] (bimekizumab) for treating hidradenitis suppurativa Read More 29 Sep 2026 UCB data presented at 2026 AANEM Annual Meeting and MGFA Scientific Session underscore leadership in advancing targeted treatments for gMG Read More 9 Sep 2026 UCB receives U.S. FDA Breakthrough Therapy Designation for CIMZIA[®] (certolizumab pegol) in pregnant women with antiphospholipid syndrome (APS) Read More 8 Sep 2026 UCB opens ‘Expressing Epilepsy’ art exhibition featuring acclaimed artists living with epilepsy Read More 1 Sep 2026 UCB presents data at EEC 2026 highlighting continued leadership in epilepsy and developmental and epileptic encephalopathies Read More 31 Aug 2026 UCB Comes to Agreement with U.S. Government to Lower the Cost of Medicine and Strengthen U.S. Manufacturing Read More Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Page 1 of 66 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe